Portfolio (Quarterly)
Guide ↗
Persistent Asset Partners Ltd
· CIK 0002056052| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 41 | — CALL | GOSSAMER BIO INC | — | 2,401.0 | $328K | 0.15% | +472.0 | +24.5% | $136.74 | — |
| 42 | — CALL | OCULAR THERAPEUTIX INC | — | 1,459.0 | $311K | 0.14% | +1K | +366.1% | $212.85 | — |
| 43 | FHTX | FOGHORN THERAPEUTICS INC | Healthcare | 47,108.0 | $254K | 0.11% | +36K | +311.8% | $5.40 | -30.0% |
| 44 | RARE | ULTRAGENYX PHARMACEUTICAL IN | Healthcare | 11,029.0 | $254K | 0.11% | +9K | +429.7% | $23.00 | +5.9% |
| 45 | — | AYTU BIOPHARMA INC | — | 79,415.0 | $206K | 0.09% | +17K | +27.2% | $2.60 | — |
| 46 | — CALL | ARBUTUS BIOPHARMA CORP | — | 1,484.0 | $191K | 0.09% | +292.0 | +24.5% | $128.59 | — |
| 47 | — | PELTHOS THERAPEUTICS INC | — | 6,007.0 | $186K | 0.08% | +4K | +150.0% | $31.00 | — |
| 48 | — CALL | KODIAK SCIENCES INC | — | 80.0 | $182K | 0.08% | +16.0 | +25.0% | $2275.97 | — |
| 49 | EQ | EQUILLIUM INC | Healthcare | 93,123.0 | $144K | 0.07% | +24K | +35.0% | $1.55 | +23.5% |
| 50 | PRQR | PROQR THRAPEUTICS N V | Healthcare | 45,154.0 | $91K | 0.04% | +9K | +24.5% | $2.02 | -25.2% |
| 51 | — PUT | CORMEDIX INC | — | 427.0 | $59K | 0.03% | +198.0 | +86.5% | $138.75 | — |
| 52 | — | NEUPHORIA THERAPEUTICS INC | — | 13,403.0 | $52K | 0.02% | +8K | +173.1% | $3.88 | — |
| 53 | — | YATSEN HLDG LTD | — | 10,332.0 | $40K | 0.02% | +5K | +106.6% | $3.89 | — |
| 54 | — CALL | SELLAS LIFE SCIENCES GROUP I | — | 1,145.0 | $37K | 0.02% | +225.0 | +24.5% | $32.50 | — |
| 55 | — CALL | MOONLAKE IMMUNOTHERAPEUTICS | — | 126.0 | $30K | 0.01% | +65.0 | +106.6% | $240.41 | — |
| 56 | PRTC | PURETECH HEALTH PLC | Healthcare | 1,759.0 | $29K | 0.01% | +74.0 | +4.4% | $16.70 | +2.3% |
| 57 | — PUT | ROIVANT SCIENCES LTD | — | 860.0 | $26K | 0.01% | +169.0 | +24.5% | $30.03 | — |
| 58 | — PUT | TRAVERE THERAPEUTICS INC | — | 134.0 | $13K | 0.01% | +133.0 | +10000.0% | $97.61 | — |
| 59 | — PUT | CORVUS PHARMACEUTICALS INC | — | 142.0 | $8K | 0.00% | +28.0 | +24.6% | $52.87 | — |
| 60 | — PUT | CASSAVA SCIENCES INC | — | 30.0 | $2K | 0.00% | +6.0 | +25.0% | $54.33 | — |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
56.7%
Technology
14.5%
Financial Services
14.2%
Consumer Cyclical
3.6%
Communication Services
3.5%
Energy
3.5%
Basic Materials
3.0%
Consumer Defensive
0.6%
Industrials
0.4%